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Objectives: Ebola and Marburg viruses (EBOVs and MARVs, respectively) are
causative agents of severe hemorrhagic fever with high mortality rates in
humans and nonhuman primates. In 2014, there was a major Ebola outbreak in
various countries in West Africa, including Guinea, Liberia, Republic of Sierra
Leone, and Nigeria. EBOV and MARV are clinically difficult to diagnose and
distinguish from other African epidemic diseases. Therefore, in this study, we
aimed to develop a method for rapid identification of the virus to prevent the
spread of infection.
Methods: We established a conventional one-step reverse transcription-
polymerase chain reaction (RT-PCR) assay for these pathogens based on the
Superscript Reverse Transcriptase-Platinum Taq polymerase enzyme mixture.
All assays were thoroughly optimized using in vitro-transcribed RNA.
Results: We designed seven primer sets of nucleocapsid protein (NP) genes
based on sequences from seven filoviruses, including five EBOVs and two MARVs.
To evaluate the sensitivity of the RT-PCR assay for each filovirus, 10-fold serial
dilutions of synthetic viral RNA transcripts of EBOV or MARV NP genes were used
to assess detection limits of viral RNA copies. The potential for these primers to
cross react with other filoviruses was also examined. The results showed that
the primers were specific for individual genotype detection in the examined
filoviruses.
Conclusion: The assay established in this study may facilitate rapid, reliable
laboratory diagnosis in suspected cases of Ebola and Marburg hemorrhagic
fevers.1. Introduction
Filoviruses are RNA viruses that belong to the
family Filoviridae, which includes zoonotic pathogens
of Ebola viruses (EBOVs), Marburg viruses (MARVs),ase Control and Prevention.
reativecommons.org/licensand Cuevaviruses. EBOVs and MARVs cause Ebola
and Marburg hemorrhagic fevers, respectively [1].
These viruses cause severe and often fatal hemorrhagic
fever, with case fatality rates ranging from 25% to 90%
depending on the strain or species.Published by Elsevier Korea LLC. This is an open access article
es/by-nc-nd/4.0/).
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with different pathogenicities [2]. Zaire EBOV
(ZEBOV), the most lethal species (case fatality rate of
up to 90%), has caused numerous human outbreaks
between 1976 and 2008 in the Democratic Republic of
the Congo, Republic of the Congo, and Gabon [3,4].
Sudan EBOV (SEBOV; case fatality rate of approx.
50%) has caused three documented outbreaks in Sudan
and one in Uganda [5,6]. Taı¨ Forest EBOV (TEBOV;
previously known as Coˆte d’Ivoire Ebola virus) has been
linked to a single, nonfatal human case [7], and the
newly discovered Bundibugyo EBOV (BEBOV) caused
an outbreak with a 25% case fatality rate in 2007 in
Uganda [8]. Reston EBOV (REBOV), which has caused
outbreaks in nonhuman primates and swine in the
Philippines, appears to be nonpathogenic in humans [9].
MARV consists of one species with two members,
namely, Ravn virus (RMARV) and MARV; RMARV
includes four strains [MARV-Popp, MARV-Musoke
(MMARV), MARV-Ozolin, and MARV-Angola] [10].
MARV has been shown to be responsible for at least
nine outbreaks since 1967, with four occurring in the
past decade, including a recent outbreak that began in
September 2012 in Uganda [11]. The increased fre-
quency of MARV outbreaks together with the fact that
these viruses are potential agents of bioterrorism has
increased public health concern regarding filoviruses.
A number of diagnostic methods are available for the
detection and identification of filoviruses. These
methods include virus isolation, enzyme-linked immu-
nosorbent assays for detection of antigen or antibodies,
reverse transcription-polymerase chain reaction (RT-
PCR), and electron microscopy, all of which have
played major roles in the diagnosis of filovirus in-
fections. In particular, RT-PCR targeting viral nucleic
acid is a rapid, sensitive technique to detect filoviruses.Table 1. Primers for reverse transcription-polymerase chain rea
Virus Primer Sequence (
BEBOV Forward GCAGAAATATGCTG
Reverse ATCATCCTCGTCCTC
REBOV Forward CCAACAATATGCTG
Reverse CATCCTCATGATCGT
SEBOV Forward ACACGTGAGTTGGA
Reverse GTCATCGTCGTCGTC
TEBOV Forward AATCTCGCGAGCTTG
Reverse CTCGTCACCATCTTC
ZEBOV Forward CGAACTTGACCATCT
Reverse TCCTCGTCGTCCTCG
MMARV Forward AGGCGACATGAACA
Reverse TCGTCCTCATTCAGC
RMARV Forward GCGACATGAACACC
Reverse ATTTTCAAGAGTATC
BEBOVZ Bundibugyo EBOV; bpZ base pair; MARVZMarburg virus; M
virus; SEBOVZ Sudan EBOV; TEBOVZ Taı¨ Forest EBOV; ZEBOVZ ZaThere are a number of commercial and in-house PCR
assays for detection of filoviruses with different targets.
In this study, we developed a one-step RT-PCR
method using primers for amplifying a specific RNA
sequence by expressing the nucleocapsid protein (NP) of
EBOV or MARV. Using this method, the presence of
EBOV or MARV genes in the samples may be identified
more accurately and detected more rapidly. Moreover,
through application of specific primers, this method
could be used for specific detection of seven types of
filoviruses, including the five known EBOVs and two
known MARVs.2. Materials and methods
2.1. Primers design
Nucleotide sequences of the N-protein-encoding
segments of seven known EBOVs and MARVs were
aligned using the CLUSTAL W multiple alignment al-
gorithm (MegAlign program, Lasergene sequence
analysis software; DNASTAR Inc., Madison, WI, USA)
to identify conserved regions. Primers for each segment
were designed using Primer Express software (Version
3.0; PE Applied Biosystems, Foster City, CA, USA).
The specificity of each primer was checked using the
Basic Local Alignment Search Tool search against the
National Center for Biotechnology Information database
and then appraised using a primer selection program in
Lasergene software. The sequences and details of
primers are listed in Table 1.
2.2. Synthesis of RNA transcripts
Seven templates from the MMARV NP gene
(2,088 nt), the SEBOV NP gene (2,217 nt), the TEBOV
NP gene (2,220 nt), the BEBOV NP gene (2,220 nt), thection used in the study.
50/30) Position Size (bp)
AATCTCGTGAAC 1062 418
AAGGTCAAAA 1479
AGTCCAGAGAA 1062 419
CAAGATCG 1480
CAACCTT 1078 402
CAAATTGAA 1479
ACCAT 1076 404
AAGGTCAAA 1479
TGGACTTG 1083 399
TCTAGAT 1481
TCAGGAAATT 1012 398
AGTGCAAAT 1409
AGGAAATTC 1014 412
CTCGTCTTCG 1425
MARVZMARV-Musoke; REBOVZReston EBOV; RMARVZ Ravn
ire EBOV.
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(2,220 nt), and the ZEBOV NP gene (2,220 nt) were
cloned into pET 28a (Novagen, Madison, WI, USA).
The template plasmids were linearized by digestion with
the HindIII restriction enzyme. The RNA transcripts
were synthesized using an mMESSAGE mMACHINE
T7 kit (Ambion, Austin, TX, USA). The residual tem-
plate DNA after in vitro transcription was removed by
TURBO DNase digestion, and the RNA was purified
using an RNA purification procedure.2.3. One-step RT-PCR
Synthesized RNAs were extracted using the TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. The final product wasFigure 1. Sensitivity of conventional RT-PCR, amplified with s
limit of filoviral RNAs using RT-PCR and 10-fold serial diluti
above the lanes. BEBOVZ Bundibugyo EBOV; EBOVZ Ebol
control; MARVZMarburg virus; MMARVZMARV-Musoke
PCRZ reverse transcription-polymerase chain reaction; SE
ZEBOVZ Zaire EBOV.dissolved in 50 mL RNase-free water. The one-step RT-
PCR was performed using a DiaStar 2X OneStep RT-
PCR premix kit (SolGent, Daejeon, South Korea) with
designed primers. The RT-PCR conditions were as fol-
lows: an initial step of 30 minutes at 50C for reverse
transcription and 15 minutes at 95C for denaturation;
35 cycles of 20 seconds at 95C, 40 seconds at 58C,
and 30 seconds at 72C; and a final extension step of 5
minutes at 72C.3. Results
3.1. Analytical sensitivity and reproducibility
To evaluate the sensitivity of the RT-PCR assay for
filovirus (5 EBOVs and 2 MARVs), 10-fold serialpecific primers for filoviruses. Determination of the detection
ons of RNA transcripts. Input RNA dilutions are indicated
a virus; Lane MZ 1-kb DNA ladder; Lane NCZ negative
; REBOVZ Reston EBOV; RMARVZ Ravn virus; RT-
BOVZ Sudan EBOV; TEBOVZ Taı¨ Forest EBOV;
Figure 2. Specificity of conventional RT-PCR, amplified with specific primers for filoviruses. BEBOVZ Bundibugyo EBOV;
EBOVZ Ebola virus; Lane BZ primers for the Bundibugyo strain; Lane MZ primers for the Musoke strain; Lane
NCZ negative control; Lane REZ primers for the Reston strain; Lane RMZ primers for the Ravn strain; Lane SZ primers for
the Sudan strain; Lane TZ primers for the Tai Forest strain; Lane ZZ primers for the Zaire strain; MARVZMarburg virus;
MMARVZMARV-Musoke; REBOVZ Reston EBOV; RMARVZ Ravn virus; RT-PCRZ reverse transcription-polymerase
chain reaction; SEBOVZ Sudan EBOV; TEBOVZ Taı¨ Forest EBOV; ZEBOVZ Zaire EBOV.
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or MARV NP genes were used to assess detection
limits of viral RNA copy or virus infection load. The
starting dilution was 50 ng/mL. The detection limits of
the RT-PCR assays were 107 for BEBOV, TEBOV,
and ZEBOV and 108 for REBOV and SEBOV. In thecase of MARV, the detection limits of MMARV and
RMARV were 107 and 105, respectively (Figure 1).
In the RT-PCR assay, with the exception of RMARV,
most viral genes were detectable at a 10-million-fold
diluted concentration (5 fg/mL). However, the detection
limit for RMARV was slightly higher (500 fg/mL). In
Detection of Ebola and Marburg viruses by RT-PCR 209other words, these RT-PCR assays were able to detect
most of the specific targets at a similar dilution. There
were no significant differences in detection limits or
reproducibility using each of the primer sets.
3.2. Analytical specificity
We compared seven primer sets of NP genes based
on sequences from seven filovirus strains. To assess the
potential for these primer sequences to cross react with
other filoviruses, the assays were tested against synthetic
RNA transcripts of the BEBOV, TEBOV, ZEBOV,
REBOV, SEBOV, MMARV, and RMARV NP genes.
For each primer set, no positive results were obtained
for other RNA transcripts (Figure 2). As a result, the
primer set for each viral NP gene was confirmed to
specifically detect only its own viral NP gene.4. Discussion
In general, conventional RT-PCR is performed to
detect known sequences. However, because this method
has high specificity for strains belonging to EBOVs and
MARVs, differential detection is possible in unknown
samples. In addition, RT-PCR is typically performed at
a concentration of 50e100 ng RNA; however, the cur-
rent method allowed for detection of the viral gene at
very low concentrations (5 fg/mL = 4,420 copies). Thus,
our current report showed that the virus could be
detected using only very small amounts of RNA
extracted from the serum. Huang et al [12] reported the
detection of NP of ZEBOV and MARV by real-time
TaqMan PCR assay. This assay could detect 10,000
copies of viral RNA of ZEBOV or 1,000 copies of viral
RNA of MARV. A comparison of our data with those of
Huang et al [12] suggests that our gel-based one-step
RT-PCR assay has sufficiently high specificity and
sensitivity to detect filoviruses. Moreover, the RT-PCR
assays designed in this study were suitable for the dif-
ferential detection of the seven viruses examined herein.
These results represent an important advancement in
detection of viruses by RT-PCR.
Rapid identification of the virus is required to prevent
spread of the infection. Thus, development of more
rapid, simple, sensitive, and specific real-time TaqMan
PCR assay for the diagnosis of filoviruses is needed.
However, the development of filovirus detection
methods based on nucleic acid amplification and appli-
cable to clinical samples has been limited. Therefore,it is necessary to study diagnosis of filoviruses with fi-
lovirus isolates in Biosafety Level 4 laboratories in the
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